News for hackers. Stuff that matters.
Re:Compass Pathways' Phase IIb psilocybin trial shows reduce... by amelius on Wednesday November 10, 2021 @10:51AM (#29176012)
29.1% effective

Headline could be more informative by including this number.

Re:Compass Pathways' Phase IIb psilocybin trial shows reduce... by savant_penguin on Wednesday November 10, 2021 @11:01AM (#29176166)
With the placebo group too

"Overall, 29.1% of patients in the highest-dose group were in remission three weeks after treatment, compared to 7.6% of those in the control group, "

Re:Compass Pathways' Phase IIb psilocybin trial shows reduce... by kemayo on Wednesday November 10, 2021 @11:20AM (#29176450)
In remission after three weeks is pretty impressive, too. There's many antidepressants which take a lot longer to ramp up to being effective, even assuming they work for you.
Re:Compass Pathways' Phase IIb psilocybin trial shows reduce... by kingkawn on Wednesday November 10, 2021 @11:00AM (#29176151)
That number is misleading without context for how effective other drugs are and in comparison to placebo. Given that placebo was ~8% effective this is a highly promising treatment.
Re:Compass Pathways' Phase IIb psilocybin trial shows reduce... by wufufufu on Wednesday November 10, 2021 @11:19AM (#29176434)
I think that was the control group, not placebo. But I didn't read the study in depth.
Re:Compass Pathways' Phase IIb psilocybin trial shows reduce... by kingkawn on Thursday November 11, 2021 @10:00AM (#29188511)
Control groups are given placebos…
Re:Compass Pathways' Phase IIb psilocybin trial shows reduce... by sleepysysadmin on Wednesday November 10, 2021 @11:07AM (#29176268)
So more effective than antidepressants?

Great news!

Re:Compass Pathways' Phase IIb psilocybin trial shows reduce... by wufufufu on Wednesday November 10, 2021 @11:17AM (#29176393)
Do you have a source? I don't think it is "more effective" in terms of the remission rate. That being said, in this hypothetical world where you can choose between shrooms and SSRIs, you would have to compare the side effects as well.
Re:Compass Pathways' Phase IIb psilocybin trial shows reduce... by rory on Wednesday November 10, 2021 @11:31AM (#29176587)
21% delta in remission rate vs. placebo is higher than both SSRIs and bupropion in this study [0] for example (11% for both). This is also a single dose which is amazing.

[0] https://pubmed.ncbi.nlm.nih.gov/16086611/

Re:Compass Pathways' Phase IIb psilocybin trial shows reduce... by sleepysysadmin on Wednesday November 10, 2021 @01:39PM (#29178536)
>Do you have a source? I don't think it is "more effective" in terms of the remission rate.

I actually look at the broader picture: https://pubmed.ncbi.nlm.nih.gov/20616621/

There's clear evidence that the antidepressant companies have inflated numbers and the actual numbers seem to suggest it's more like ~7% effective on par with placebo levels.

The conclusion made is that we need to look at alternatives.

>That being said, in this hypothetical world where you can choose between shrooms and SSRIs, you would have to compare the side effects as well.

True. SSRIs even at same efficacy would be out of the question given the risk. Mushrooms on the otherhand? Kind of recreationally used.

Flipside, we have a very clear problem. As marijuana legalizes, we are going to re-evaluate all these other psychedelics. In addition to the political situation of the losing war of drugs. We may politically seeing marketing on why we need to legalize. So we need more info.